(1)
Hamza, S. A.; Haddad, N. I. A.; Gawwam, G. A. The Rate Of Disease Progression In MS Patients Treated With Rituximab And Ocrelizumab: A Comparative Study. IJASIS 2026, 335-345. https://doi.org/10.29284/x4mwhb26.